Safety Concerns About Saltz Regimen Were Statistical Artifact, ODAC Finds.
AACI: von Eschenbach “Wonderful Choice” For NCI Director, Knows How Centers Work. Cancer Centers Pleased With Bush Choice For NCI.
Campus-Dweller Rabson Finds Comfort In NIH Security.
Endostatin Enters Phase II Trial For Neuroendocrine Tumors.
Siemens To Provide Technology To DxTx For Lung Cancer Detection.
Myriad In Partnership To Market Products.
Computer-Aided Detection Approved For Mammograms.
Trending Stories
- NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - NIH cuts threaten U.S. edge in biomedical research: “We are giving China the opportunity of a lifetime”
Cancer research also took center stage at Senate appropriations hearing - The White House “skinny budget” document cuts NIH by nearly 40%
The cuts are consistent with the previously leaked “passback” document - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- Did Vinay Prasad need to mention the Nazis to make a point on the U.S. pandemic response?
- AACI letter to NIH’s Bhattacharya opposes centralizing review of CCSG